Folgen
Bárbara Rentroia-Pacheco
Bárbara Rentroia-Pacheco
Erasmus Medical Center
Bestätigte E-Mail-Adresse bei erasmusmc.nl
Titel
Zitiert von
Zitiert von
Jahr
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model
AMM Eggermont, D Bellomo, SM Arias-Mejias, E Quattrocchi, ...
European Journal of Cancer 140, 11-18, 2020
392020
Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary
I Johansson, D Tempel, JT Dwarkasing, B Rentroia-Pacheco, J Mattsson, ...
European Journal of Surgical Oncology 48 (2), 320-325, 2022
222022
Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: a US cohort study
A Yousaf, FJ Tjien‐Fooh, B Rentroia‐Pacheco, E Quattrocchi, A Kobic, ...
International journal of dermatology 60 (7), 851-856, 2021
222021
Trypanosoma brucei triggers a broad immune response in the adipose tissue
H Machado, T Bizarra-Rebelo, M Costa-Sequeira, S Trindade, T Carvalho, ...
PLoS pathogens 17 (9), e1009933, 2021
182021
Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies
S Tokez, ZC Venables, LM Hollestein, H Qi, EM Bramer, ...
Journal of the American Academy of Dermatology 87 (1), 64-71, 2022
162022
Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I–II melanoma patients at risk of disease relapse
EEAP Mulder, I Johansson, DJ Grünhagen, D Tempel, ...
Cancers 14 (12), 2854, 2022
132022
Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model
B Rentroia-Pacheco, S Tokez, EM Bramer, ZC Venables, ...
EClinicalMedicine 63, 2023
52023
Clinicopathologic models predicting non‐sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
B Rentroia‐Pacheco, FJ Tjien‐Fooh, E Quattrocchi, A Kobic, R Wever, ...
Journal of surgical oncology 125 (3), 516-524, 2022
52022
Independent validation study of a CP-GEP model (Merlin Assay) to identify patients with melanoma who can safely forgo sentinel lymph node biopsy
I Johansson, D Tempel, JT Dwarkasing, B Rentroia-Pacheco, J Mattsson, ...
2*
Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk for disease relapse
E Mulder, I Johansson, D Grünhagen, D Tempel, B Rentroia-Pacheco, ...
European Journal of Surgical Oncology 49 (2), e33-e34, 2023
12023
Weighted metrics are required when evaluating the performance of prediction models in nested case–control studies
B Rentroia-Pacheco, D Bellomo, IMM Lakeman, M Wakkee, LM Hollestein, ...
BMC Medical Research Methodology 24 (1), 115, 2024
2024
Efficient study design for the discovery of a gene expression signature predicting metastasis in cutaneous squamous cell carcinoma
B Rentroia-Pacheco, L Pozza, YT Chen, D Huigh, CJ Eggermont, ...
Cancer Research 84 (6_Supplement), 4869-4869, 2024
2024
Avoiding the pitfalls in developing and validating prediction models for rare outcomes in nested case-control
B Rentroia-Pacheco, D Bellomo, IMM Lakeman, M Wakkee, LM Hollestein, ...
Cancer Research 84 (6_Supplement), 4868-4868, 2024
2024
Beyond staging systems in cutaneous squamous cell carcinoma: Validation of two thresholds for a model-estimated metastatic risk
OFM Steijlen, L Pozza, B Rentroia-Pacheco, CJ Eggermont, D Bellomo, ...
Cancer Research 84 (6_Supplement), 3463-3463, 2024
2024
Integrating a Clinicopathological Risk Prediction Model into the European Guideline for Cutaneous Squamous Cell Carcinoma
O Steijlen, L Pozza, B Rentroia-Pacheco, C Eggermont, D Bellomo, ...
EJC Skin Cancer 2, 2024
2024
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–15